Clinical Trial Results: A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tolerability of different doses of BI 3731579 in healthy volunteers; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• BI 3731579

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: TERMINATED | Results posted: 2026-08-10